Article
PTPN22 1858C>T polymorphism is strongly associated with rheumatoid arthritis but not with a response to methotrexate therapy.
International immunopharmacology - 1 Dec 2010
Majorczyk Edyta, Pawlik Andrzej, Kuśnierczyk Piotr
Abstract excerpt
PTPN22 (protein tyrosine phosphatase non-receptor type 22) 1858C>T single-nucleotide polymorphism (SNP) is one of the genetic risk factors of rheumatoid arthritis (RA). However, its role in the response of RA patients to therapy is not known. We examined a possible association of this SNP with a response of RA patients to methotrexate (MTX) treatment. RA was diagnosed in 371 patients according to the American...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
